![Vertical Shifts in Self-Administration Dose–Response Functions Predict a Drug-Vulnerable Phenotype Predisposed to Addiction | Journal of Neuroscience Vertical Shifts in Self-Administration Dose–Response Functions Predict a Drug-Vulnerable Phenotype Predisposed to Addiction | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/20/11/4226/F4.large.jpg)
Vertical Shifts in Self-Administration Dose–Response Functions Predict a Drug-Vulnerable Phenotype Predisposed to Addiction | Journal of Neuroscience
![Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment - ScienceDirect Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0048969712013927-fx1.jpg)
Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment - ScienceDirect
![Histopathological staging of the ileum after administration of low (A)... | Download Scientific Diagram Histopathological staging of the ileum after administration of low (A)... | Download Scientific Diagram](https://www.researchgate.net/publication/323916438/figure/fig2/AS:614045640060940@1523411297519/Histopathological-staging-of-the-ileum-after-administration-of-low-A-and-high-B-doses.png)
Histopathological staging of the ileum after administration of low (A)... | Download Scientific Diagram
![Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet](https://www.thelancet.com/cms/asset/643af9b2-1d35-4487-bda0-687f2e80ab01/gr1.jpg)
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
![Children | Free Full-Text | Introducing Less-Invasive Surfactant Administration into a Level IV NICU: A Quality Improvement Initiative Children | Free Full-Text | Introducing Less-Invasive Surfactant Administration into a Level IV NICU: A Quality Improvement Initiative](https://pub.mdpi-res.com/children/children-08-00580/article_deploy/html/images/children-08-00580-ag.png?1625644378)
Children | Free Full-Text | Introducing Less-Invasive Surfactant Administration into a Level IV NICU: A Quality Improvement Initiative
![Tenofovir Alafenamide Pharmacokinetics in Renal Impairment: Potential for Administration without Dose Adjustment Tenofovir Alafenamide Pharmacokinetics in Renal Impairment: Potential for Administration without Dose Adjustment](https://www.natap.org/2013/images/032213/032213-3/CROI1.gif)
Tenofovir Alafenamide Pharmacokinetics in Renal Impairment: Potential for Administration without Dose Adjustment
![Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems | Nature Reviews Drug Discovery Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41573-023-00670-0/MediaObjects/41573_2023_670_Fig1_HTML.png)